Cooper Pharma News Today

The product is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older

Cipla EU acquired an additional 15.1 percent of Cipla Maroc SA, Morocco, which is a JV between Cooper Pharma and Cipla EU.

Korea’s leading pharmaceutical firm Daewoong Pharmaceutical aims to achieve a fivefold increase in overseas sales within the next five years through the introduction of new drugs, according to the company's global business head on Friday. “My personal goal is to see Daewoong’s overseas sales reach 1 trillion won ($772.6 million) within the next five years,” said Kim Do-young, head of Daew...

Biomed Israel International Life Science and HealthTech conference in Tel Aviv May 16-18 will hold several events with senior healthcare professionals from the Abraham Accords partners.

Propofol was contaminated, inquiry told

New Delhi: Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, joint venture and subsidiary of Cipla EU in...

The JV Co. has enabled Cipla to establish a front-end participation in Moroccos pharmaceutical market.

Electric vehicles, aerospace and pharmaceuticals are at the heart of Morocco’s bid to become a high-tech hub positioned for the European markets.

Rwanda and the Arab Bank for Economic Development in Africa (BADEA) have signed a financing agreement worth US$ 20 million (Approximately Frw 20 billion) to support the development of basic infrastructure at Kigali Innovation City (KIC) project. KIC is a flagship government program aimed at creating an ecosystem centered around high-tech, innovation and talent development […]

Can Morocco become the next « African Hub » of the pharmaceutical industry? Tuesday, April 20, 2021 4:26 AM UTC Since the start of the pandemic, all eyes are on the pharmaceutical industry. In Morocco, this sector constitutes the second largest chemical activity after phosphates and occupies the second place on the African continent, where the local production of medicines is one of the main weak points. Producing only 3% of it...